Sinovac’s experimental COVID-19 vaccine triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed.
Fuente: Youtube
Sinovac’s experimental COVID-19 vaccine triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed.
Fuente: Youtube
